Healthcare-associated infections (HAIs) are the ones that are contracted by
patients while they are receiving treatment for another medical condition in a
healthcare setting. Thus HAIs can be acquired at any place where healthcare is
delivered. HAIs are generally caused by infectious agents, pathogens, fungi,
bacteria, and viruses. The risk factors associated with these infections are
use of indwelling medical devices, surgeries, injections, contaminated
healthcare environment, communication of diseases between workers and patients,
and improper use of antibiotics.
To Read The Complete
Report with TOC :-
HAIs are a major cause of mortality and morbidity on a worldwide
scale. Each year HAIs lead to thousands of deaths. A majority of HAIs include
conditions such as urinary tract infections, surgical site infections,
bloodstream infections, gastroenteritis, and pneumonia. The overall HAI
treatment market can be classified on the basis of devices and pharmaceuticals
used for HAI treatment. The major pharmaceuticals used in HAI treatment are
viral pharmaceuticals, bacterial pharmaceuticals, and fungal pharmaceuticals.
The major drug classes used in the pharmaceuticals segment are B-Lactam
Antibiotics, cephalosporins, quinolones, glycopeptides, lincosamides,
polypeptides, carbapenems, lipopeptides, penicillins, macrolides, tuberculosis,
etracyclines, sulfonamides, and other such formulations. The medical devices
segment can be further categorized into catheters and ventilation devices and
in-line sterile IV filtration.
The U.S. is the largest market for HAI treatment pharmaceuticals
and devices. In the U.S., each year more than 1.5 million patients contract
HAI. Recently Partners for Patients had introduced a USD 500 million grant to help
hospitals and other healthcare providers to reduce HAIs in the U.S. it is
expected that if successful, this program will save USD 50 billion of U.S.
Medicare over the next ten years. The other markets for HAI treatment devices
and pharmaceuticals are Asia-Pacific, Europe, and the Rest of the World. Some
of the major players of this market include companies such as Merck, Johnson
& Johnson, GlaxoSmithKline, Sharklet Technologies, Ondine Biomedical and
some others.
To Buy a Copy Of This
Report :-
This research report analyzes this market depending on its
market segments, major geographies, and current market trends. Geographies
analyzed under this research report include
·
North
America
·
Asia
Pacific
·
Europe
·
Rest
of the World
This report provides comprehensive analysis of
·
Market
growth drivers
·
Factors
limiting market growth
·
Current
market trends
·
Market
structure
·
Market
projections for upcoming years
This report is a complete study of current trends in the market,
industry growth drivers, and restraints. It provides market projections for the
coming years. It includes analysis of recent developments in technology,
Porter’s five force model analysis and detailed profiles of top industry
players. The report also includes a review of micro and macro factors essential
for the existing market players and new entrants along with detailed value
chain analysis.
Reasons for Buying this Report
·
This
report provides pin-point analysis for changing competitive dynamics
·
It
provides a forward looking perspective on different factors driving or
restraining market growth
·
It
provides a technological growth map over time to understand the industry growth
rate
·
It
provides a seven-year forecast assessed on the basis of how the market is
predicted to grow
·
It
helps in understanding the key product segments and their future
·
It
provides pin point analysis of changing competition dynamics and keeps you
ahead of competitors
·
It
helps in making informed business decisions by having complete insights of
market and by making in-depth analysis of market segments
·
It
provides distinctive graphics and exemplified SWOT analysis of major market
segments
No comments:
Post a Comment